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Asthma is a heterogeneous condition characterised by chronic 
inflammation and variable expiratory airflow limitation,[1] as well as 
airway reversibility. Worldwide, asthma is the most common chronic 
non-communicable disease in children. The most recent global 
estimate of asthma in adults and children (2008 - 2010) suggests that 
as many as 334 million people have asthma.[2] The historical view of 
asthma being a disease of high-income countries no longer holds. 
Most people affected reside in low- and middle-income countries, 
where asthma prevalence is estimated to be increasing fastest, 
while plateauing in high-income countries. Asthma carries a high 
economic cost to society and the healthcare system, with costs being 
both direct (hospitalisation, medications and outpatient visits) and 
indirect (related to absenteeism and loss of productivity). Improving 
access to care and medications, coupled with use of and adherence 
to evidence-based treatments, can reduce the economic burden of 
asthma. 
Accurate diagnosis of childhood asthma may be especially 
challenging in African settings, where respiratory infectious 
diseases predominate. In non-English-speaking populations, asthma 
terminology may not be easily translated into local languages. In 
resource-constrained areas, poor access to healthcare and lack of 
availability of lung function testing to confirm the diagnosis also 
contribute to delayed diagnosis.[3] Questionnaire-based studies must 
be interpreted with caution, as these often rely on literate populations 
who understand the meaning of words such as ‘wheezing’ and 
‘asthma’; this group of individuals may be prone to recall bias.[3] 
Despite these limitations, the International Study of Asthma and 
Allergies in Childhood (ISAAC) has provided the most reliable 
global, comparative data on the prevalence of asthma and other 
allergic conditions in children, using standard written and video 
questionnaires, enabling comparison of asthma prevalence between 
different parts of the world.
Objectives
We reviewed the current literature on the burden of asthma in South 
Africa (SA) in the context of other low- and middle-income countries 
and on rural and urban differences in prevalence and severity of asthma.
Methods
The SA Childhood Asthma Working Group (SACAWG) convened in 
January 2017 with six task groups, each headed by a leader (Appen-
dix A), constituting the editorial committee on assessment of asthma 
epidemiology, diagnosis, control, treatments, novel treatments and 
self-management plans. The task groups reviewed the available 
scientific literature on the burden of asthma from high-quality 
datasets and any local data on asthma prevalence and severity in 
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children, and graded the level of evidence and recommendations 
based on the current evidence. 
Asthma prevalence
Worldwide asthma prevalence
ISAAC phase I and phase III studies, using identical questionnaires, 
were performed ~7 years apart and enabled the investigation of time 
trends with regard to the symptoms of asthma. Studies were carried 
out in two age groups: children aged 6 - 7 years and adolescents aged 
13 - 14 years.[4-6] The large number of children surveyed (>1 million), 
centres (N=233) and countries (N=98) that participated in ISAAC 
phase III, made this the most comprehensive global survey of child-
hood asthma to date.[7] 
The current overall worldwide prevalence of asthma (ISAAC 
phase III), measured by reported symptoms in children aged 6 - 7 years 
and 13 - 14 years, was 11.5% and 14.1%, respectively.[8] There was a 
significant variation in the prevalence of asthma between countries 
(Table 1). The prevalence of asthma in 13 - 14-year-old black African 
children was 15.3%, which was higher than the global average.[6] 
Moreover, the prevalence of childhood asthma in African countries 
is increasing, compared with that in many high-income settings, 
where it has stabilised or is decreasing.[3,4] Only two African centres in 
addition to SA centres included the younger age group of 6 - 7-year-
olds. In these centres in Nigeria and Mozambique, the 12-month 
prevalence of wheeze was 5.6% and 13.3%, respectively.[9] Overall, 
in Africa, the 12-month prevalence of wheeze was 10.0% in the 6 - 
7-years age group. Globally, the current prevalence of wheeze in this 
age group is 11.5% and that of severe wheeze 4.9%. 
The high, increasing prevalence of childhood asthma in Africa 
reported by ISAAC has been supported by studies measuring 
bronchial hyper-responsiveness (BHR) for diagnosing asthma. Such 
studies have shown a consistent increase in asthma prevalence in 
rural and urban settings in African countries.[10-14] Furthermore, black 
African children with asthma have been reported to have more severe 
symptoms than those in high-income countries, which may relate 
to factors such as lack of diagnosis, access to care, affordability of 
therapy, as well as environmental irritants and genetic susceptibility 
to more severe disease, or a combination of these.[15] 
Asthma prevalence in South Africa
The prevalence of asthma in SA children was measured using the 
ISAAC methodology in Cape Town in 1995 (phase I) and repeated 
7 years later in 2002 (phase III). Children aged 13 - 14 years, from all 
population groups, were included in the study.[8] In 1995, a total of 
5 178 child ren completed the questionnaire and in 2002, 5 037 child -
ren responded. 
The prevalence of lifetime and 12-month wheezing increased 
between phase I and phase III from 27.7% to 33.1% and 16.0% to 
20.3%, respectively (Table 2).[8] Similarly, the 12-month prevalence of 
night waking with wheeze, severe wheeze, exercise-induced wheeze 
and nocturnal cough all increased significantly from 1995 to 2002. 
Worryingly, approximately half of all children with asthma had 
severe, uncontrolled symptoms.[7,8] ISAAC phase III was conducted 
in a rural population in Polokwane, Limpopo, in 4 660 children 
aged 13 - 14 years. The 12-month prevalence of asthma was 18%, 
while the prevalence of severe asthma symptoms in Cape Town 
was less (6.6%).[6] Using the ISAAC phase III methodology in a 
younger cohort (N=2 437) of 6 - 7-year-old black African children in 
Polokwane, the 12-month prevalence of wheeze and severe wheeze 
was 11.2% and 5.7%, respectively.[9] In this cohort, various potential 
risk factors and asthma symptoms were investigated. Living in a rural 
area was protective, which significantly decreased the likelihood of 
wheeze by 31%. Risk factors for the increased likelihood of wheeze 
included: exposure to environmental tobacco smoke (77%), eczema 
(104%) and rhinoconjunctivitis (226%) symptoms. The presence of 
rhinoconjunctivitis increased the likelihood of severe wheeze by 107%.[9] 
Studies in SA children measuring BHR confirmed the increase in 
asthma prevalence. In 1979, the first study of asthma prevalence in SA 
Table 1. Current prevalence of asthma symptoms by world region in 6 - 7-year and 13 - 14-year age groups as measured in ISAAC 
phase III* 
Region
6 - 7 years 13 - 14 years
N n % N n %
Africa 5 865 589 10.0 66 308 10 168 15.3
Asia-Pacific 59 979 5 719 9.5 99 634 8 731 8.7
Eastern Mediterranean 40 573 3 824 9.4 51 705 4 801 9.2
Indian subcontinent 50 092 3 392 6.7 55 783 3 884 6.9
Latin America 93 774 16 256 17.3 165 900 26 350 15.9
North America 4 012 767 19.1 141 009 30 427 21.6
Northern and Eastern Europe 42 548 3 715 8.7 72 057 7 009 9.7
Oceania 13 888 3 020 21.7 36 299 6 301 17.4
Western Europe 77 722 7 487 9.6 107 673 15 483 14.4
Global total 388 811 44 799 11.5 798 685 112 630 14.1
ISAAC = International Study of Asthma and Allergies in Childhood; n = number of participants with a positive asthma-screening questionnaire.
*Adapted from Aït-Khaled et al.[6]
Table 2. Current prevalence of asthma symptoms (12-month prevalence rate of wheeze) by region in South Africa in 6 - 7-year and 
13 - 14-year age groups as measured in ISAAC phase I and phase III
Region
6 - 7 years 13 - 14 years
N % N %
Cape Town (ISAAC I) - - 5 178 16.0
Cape Town (ISAAC III) - - 5 037 20.3
Polokwane (ISAAC III) 2 437 11.2 4 660 18.0
ISAAC = International Study of Asthma and Allergies in Childhood.
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children found a 30-fold higher prevalence in urban (3.1%) compared 
with rural (0.01%) Xhosa children aged 7 - 9 years.[10] A follow-up 
study in 2003 reported an increase in asthma prevalence in urban 
and rural children, with a reduction in the urban-rural gradient.[13] 
Increased BHR was associated with rural children adopting an urban 
lifestyle. A later study measuring BHR also confirmed an increase in 
asthma prevalence in urban (15%) and rural (9%) Xhosa children, 
with a reduction in the urban-rural gradient.[14] Obesity was identified 
as a risk factor for an increase in BHR. The most recent study showed 
BHR in 16% of peri-urban black African teenagers, with high rates of 
allergen sensitisation in individuals with BHR.[15]
Risk factors for asthma
Eczema is an important risk factor for asthma, and longitudinal 
studies have shown that from one-third to one-half of children 
with eczema develop asthma.[17] In a SA study of 100 children with 
atopic dermatitis, 39% described symptoms of asthma according to 
the ISAAC questionnaire, and in 29% asthma was diagnosed by a 
doctor.[18] Asthma prevalence increased with age: at the time of the 
study asthma symptoms were present in 22% of children <2 years old, 
43% of 2 - 4-year-olds and 50% of children >4 years old.[18]
Industrial pollution is a further risk factor associated with a higher 
prevalence of asthma. A study in Durban questioned 422 learners 
(average age 10.5 years) on symptoms of asthma. In this cohort, the 
presence of symptoms that were consistent with asthma of any sever-
ity was 32%, and the prevalence of doctor-diagnosed asthma was 13.0 
- 16.5%, depending on the area surveyed. Children from areas with 
higher levels of industrial pollution had a higher prevalence of respi-
ratory health problems.[19] In a separate study in a highly pollu ted 
area in the south of Durban, which included 248 school- aged partici-
pants from grades 3 to 7, 52% had asthma of any severity, 11% had 
moderate-to-severe persistent asthma, and 21% had marked airways 
hyperreactivity on methacholine challenge testing.[20]
Asthma morbidity and mortality
Almost half of children in Cape Town who reported asthma in ISAAC 
phase III had severe symptoms.[8] Furthermore, >30% of children 
with severe asthma symptoms had never been formally diagnosed 
with asthma.[7,14] In addition to morbidity from childhood asthma, SA 
has a very high rate of asthma-related deaths, suggesting that lack of 
appropriate diagnosis, treatment or access to care may be important 
considerations.[16-18] Although SA was ranked 25th worldwide for the 
prevalence of asthma, it ranked 4th in asthma mortality in the 5 - 
34-year-old age group and 5th for asthma case fatality rates, with an 
estimated 18.5 per 100 000 asthmatics.[17,18]
Conclusion 
Childhood asthma remains a common condition, which has shown an 
increasing prevalence in urban and rural populations in SA. Of concern 
is that almost half of children in urban communities experience severe 
asthma symptoms, and many asthmatics lack a formal diagnosis and 
thus access to treatment. Exposure to tobacco smoke and living in highly 
polluted areas increase the severity of wheezing in young children.
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Appendix A. The SA Childhood 
Asthma Working Group (SACAWG)
Epidemiology: H Zar (leader), Western Cape; C Gray, Western Cape.
Diagnosis of asthma: R Masekela (leader), KwaZulu-Natal; S M Risenga, 
Limpopo; O P Kitchin, Gauteng; P Goussard, Western Cape.
Assessment of asthma control: R J Green (leader), Gauteng; D White, 
Gauteng; G Davis, Gauteng.
Pharmacotherapy: F E Kritzinger (leader), Western Cape; A Jeevana-
thrum, Gauteng; P de Waal, Free State; S Kling, Western Cape; A Vanker, 
Western Cape; T C Gray, Western Cape; J Morrison, Western Cape; 
A Puterman, Western Cape; E Zollner, Western Cape; D Rhode, Western 
Cape.
Pharmacotherapy – other therapies: A I Manjra (leader), KwaZulu-Natal; 
P M Jeena, KwaZulu-Natal; V Naidoo, KwaZulu-Natal; M Annamalai, 
KwaZulu-Natal; A van Niekerk, Gauteng.
Self-management plans: M Levin (leader), Western Cape;  S Emanuel, 
Western Cape; D Hawarden, Western Cape; H Katz, Gauteng.
